Latest Breaking News On - Company codes - Page 7 : comparemela.com

BioArctic develops new treatment for Gaucher s disease

BioArctic develops new treatment for Gaucher's disease - read this article along with other careers information, tips and advice on BioSpace

Uppsala lanOskar bossonGunilla osswaldUppsala universityVp communicationsCompany codesBrain transporterNasdaq stockholm mid cap

Key Opinion Leader Fireside Chat with Professor Richard Lafayette on the US IgAN Treatment Landscape

Key Opinion Leader Fireside Chat with Professor Richard Lafayette on the US IgAN Treatment Landscape - read this article along with other careers information, tips and advice on BioSpace

United statesMarie galayRichard lafayetteGlomerular diseases advisory groupEuropean commissionStanford glomerular disease centerYork medical collegeCompany codesStanford university medical centerEuropean union member statesMedicine at long island jewish medical centerStanford universityKey opinion leaderFireside chatIga nephropathyStanford healthcare

Innovent Releases Results of a Phase 3 Clinical Study of Tafolecimab（IBI306）in Chinese Patients with non- Familial Hypercholesterolemia at the American Heart Association (AHA) Scirntific Sessions 2022

Innovent Releases Results of a Phase 3 Clinical Study of Tafolecimab（IBI306）in Chinese Patients with non- Familial Hypercholesterolemia at the American Heart Association (AHA) Scirntific Sessions 2022
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongInnovent biologicsAdimab incyteYong huoEli lillyAmerican cardiology association annual congressAmerican heart associationPrnewswire innovent biologics incChina cardiovascular healthMd anderson cancer centerChina national medical products administrationCompany codesUniversity first hospitalIncyte corporationScientific sessions

Innovent Announces Phase Ib Results of Higher-dose Mazdutide (IBI362) in Chinese Participants with Overweight or Obesity Published in eClinicalMedicine

Innovent Announces Phase Ib Results of Higher-dose Mazdutide (IBI362) in Chinese Participants with Overweight or Obesity Published in eClinicalMedicine - read this article along with other careers information, tips and advice on BioSpace

United statesHong kongInnovent biologicsLeili gaoAdimab incyteEli lillyLinong jiCompany lillyClinical development at innoventPrnewswire innovent biologics incMd anderson cancer centerUniversity people hospitalCompany codesIncyte corporationProfessor leili gaoPeking university people

IceCure Medical s ProSense® Cryoprobes and Introducers Receive Regulatory Approval in Brazil

IceCure Medical's ProSense® Cryoprobes and Introducers Receive Regulatory Approval in Brazil - read this article along with other careers information, tips and advice on BioSpace

Ronen tsimermanEyal shamirProsense cryoprobesCompany annual report on formBrazilian health regulatory agencySecurities exchange commissionCompany codesPrnewswire icecure medical ltdSense cryoablation systemCure medicalProsense systemProsense cryoablation systemIcecure medicalPrivate securities litigation reform actRisk factorsAnnual report